A Trial of Isoniazid for the Reversion of Interferon Gamma ELISPOT in Tuberculosis (TB) Case Contacts - No Study Results Posted

A Trial of Isoniazid for the Reversion of Interferon Gamma ELISPOT in Tuberculosis (TB) Case Contacts (IRS)

This study has been completed.

Study NCT00130325 Information provided by Medical Research Council Laboratories, Gambia

First Received: August 11, 2005 Last Updated: January 12, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	June 2009
Primary Completion Date:	October 2008 (Final data collection date for primary outcome measure)